172 related articles for article (PubMed ID: 21416115)
1. Development of a model for prediction of coronary atherosclerotic regression: evaluation of high-density lipoprotein cholesterol level and peripheral blood monocyte count.
Tani S; Matsumoto M; Anazawa T; Kawamata H; Furuya S; Takahashi H; Iida K; Washio T; Kumabe N; Kobori M; Nagao K; Hirayama A
Heart Vessels; 2012 Mar; 27(2):143-50. PubMed ID: 21416115
[TBL] [Abstract][Full Text] [Related]
2. HMG-CoA reductase inhibitor (Statin) therapy and coronary atherosclerosis in Japanese subjects: role of high-density lipoprotein cholesterol.
Tani S; Nagao K; Hirayama A
Am J Cardiovasc Drugs; 2011 Dec; 11(6):411-7. PubMed ID: 22149320
[TBL] [Abstract][Full Text] [Related]
3. Association of leukocyte subtype counts with coronary atherosclerotic regression following pravastatin treatment.
Tani S; Nagao K; Anazawa T; Kawamata H; Furuya S; Takahashi H; Iida K; Matsumoto M; Washio T; Kumabe N; Hirayama A
Am J Cardiol; 2009 Aug; 104(4):464-9. PubMed ID: 19660595
[TBL] [Abstract][Full Text] [Related]
4. Coronary plaque regression and lifestyle modification in patients treated with pravastatin. - Assessment mainly by daily aerobic exercise and an increase in the serum level of high-density lipoprotein cholesterol -.
Tani S; Nagao K; Anazawa T; Kawamata H; Furuya S; Takahashi H; Iida K; Matsumoto M; Washio T; Kumabe N; Hirayama A
Circ J; 2010 May; 74(5):954-61. PubMed ID: 20234098
[TBL] [Abstract][Full Text] [Related]
5. Reverse vessel remodeling but not coronary plaque regression could predict future cardiovascular events in ACS patients with intensive statin therapy--the extended JAPAN-ACS study.
Miyauchi K; Daida H; Morimoto T; Hiro T; Kimura T; Nakagawa Y; Yamagishi M; Ozaki Y; Kadota K; Kimura K; Hirayama A; Kimura K; Hasegawa Y; Uchiyama S; Matsuzaki M;
Circ J; 2012; 76(4):825-32. PubMed ID: 22451449
[TBL] [Abstract][Full Text] [Related]
6. Association of the low-density lipoprotein cholesterol/high-density lipoprotein cholesterol ratio and body mass index with coronary plaque regression.
Tani S; Matsumoto M; Nakamura Y; Nagao K; Hirayama A
Am J Cardiovasc Drugs; 2012 Aug; 12(4):279-86. PubMed ID: 22747341
[TBL] [Abstract][Full Text] [Related]
7. Effect of pravastatin on coronary plaque volume.
Ishikawa K; Tani S; Watanabe I; Matsumoto M; Furukawa K; Nomoto K; Nomoto K; Kushiro T; Nagao K; Kanmatsuse K
Am J Cardiol; 2003 Oct; 92(8):975-7. PubMed ID: 14556877
[TBL] [Abstract][Full Text] [Related]
8. Clinically evident polyvascular disease and regression of coronary atherosclerosis after intensive statin therapy in patients with acute coronary syndrome: serial intravascular ultrasound from the Japanese assessment of pitavastatin and atorvastatin in acute coronary syndrome (JAPAN-ACS) trial.
Hibi K; Kimura T; Kimura K; Morimoto T; Hiro T; Miyauchi K; Nakagawa Y; Yamagishi M; Ozaki Y; Saito S; Yamaguchi T; Daida H; Matsuzaki M;
Atherosclerosis; 2011 Dec; 219(2):743-9. PubMed ID: 21899843
[TBL] [Abstract][Full Text] [Related]
9. The beneficial effects of raising high-density lipoprotein cholesterol depends upon achieved levels of low-density lipoprotein cholesterol during statin therapy: Implications for coronary atheroma progression and cardiovascular events.
Puri R; Nissen SE; Shao M; Kataoka Y; Uno K; Kapadia SR; Tuzcu EM; Nicholls SJ
Eur J Prev Cardiol; 2016 Mar; 23(5):474-85. PubMed ID: 25691546
[TBL] [Abstract][Full Text] [Related]
10. Impacts of estimated glomerular filtration rate on coronary atherosclerosis and plaque composition before and during statin therapy in patients with normal to mild renal dysfunction: subanalysis of the TRUTH study.
Nozue T; Yamamoto S; Tohyama S; Fukui K; Umezawa S; Onishi Y; Kunishima T; Hibi K; Terashima M; Michishita I;
Nephrology (Carlton); 2012 Sep; 17(7):628-35. PubMed ID: 22708952
[TBL] [Abstract][Full Text] [Related]
11. Association of circulating leukocyte count with coronary atherosclerosis regression after pravastatin treatment.
Tani S; Nagao K; Anazawa T; Kawamata H; Iida K; Matsumoto M; Sato Y; Hirayama A
Atherosclerosis; 2008 Jun; 198(2):360-5. PubMed ID: 18374337
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of Statin Therapy in Inducing Coronary Plaque Regression in Patients with Low Baseline Cholesterol Levels.
Wakabayashi K; Nozue T; Yamamoto S; Tohyama S; Fukui K; Umezawa S; Onishi Y; Kunishima T; Sato A; Miyake S; Morino Y; Yamauchi T; Muramatsu T; Hibi K; Terashima M; Suzuki H; Michishita I;
J Atheroscler Thromb; 2016 Sep; 23(9):1055-66. PubMed ID: 27040362
[TBL] [Abstract][Full Text] [Related]
13. Is pre-operative monocyte count-high-density lipoprotein ratio associated with postoperative acute kidney injury in isolated coronary artery bypass grafting?
Şaşkın H
Cardiovasc J Afr; 2023 Nov-Dec 23; 34(5):278-284. PubMed ID: 36420654
[TBL] [Abstract][Full Text] [Related]
14. Statins, high-density lipoprotein cholesterol, and regression of coronary atherosclerosis.
Nicholls SJ; Tuzcu EM; Sipahi I; Grasso AW; Schoenhagen P; Hu T; Wolski K; Crowe T; Desai MY; Hazen SL; Kapadia SR; Nissen SE
JAMA; 2007 Feb; 297(5):499-508. PubMed ID: 17284700
[TBL] [Abstract][Full Text] [Related]
15. Comparison of change in coronary atherosclerosis in patients with stable versus unstable angina pectoris receiving statin therapy (from the Treatment With Statin on Atheroma Regression Evaluated by Intravascular Ultrasound With Virtual Histology [TRUTH] study).
Nozue T; Yamamoto S; Tohyama S; Fukui K; Umezawa S; Onishi Y; Kunishima T; Sato A; Nozato T; Miyake S; Takeyama Y; Morino Y; Yamauchi T; Muramatsu T; Hibi K; Terashima M; Michishita I;
Am J Cardiol; 2013 Apr; 111(7):923-9. PubMed ID: 23337838
[TBL] [Abstract][Full Text] [Related]
16. High-density lipoprotein cholesterol associated with change in coronary plaque lipid burden assessed by near infrared spectroscopy.
Honda S; Sidharta SL; Shishikura D; Takata K; Di Giovanni GA; Nguyen T; Janssan A; Kim SW; Andrews J; Psaltis PJ; Worthley MI; Nicholls SJ
Atherosclerosis; 2017 Oct; 265():110-116. PubMed ID: 28881268
[TBL] [Abstract][Full Text] [Related]
17. The effect of lipid and inflammatory profiles on the morphological changes of lipid-rich plaques in patients with non-ST-segment elevated acute coronary syndrome: follow-up study by optical coherence tomography and intravascular ultrasound.
Takarada S; Imanishi T; Ishibashi K; Tanimoto T; Komukai K; Ino Y; Kitabata H; Kubo T; Tanaka A; Kimura K; Mizukoshi M; Akasaka T
JACC Cardiovasc Interv; 2010 Jul; 3(7):766-72. PubMed ID: 20650439
[TBL] [Abstract][Full Text] [Related]
18. Relation of change in apolipoprotein B/apolipoprotein A-I ratio to coronary plaque regression after Pravastatin treatment in patients with coronary artery disease.
Tani S; Nagao K; Anazawa T; Kawamata H; Furuya S; Takahashi H; Iida K; Matsumoto M; Washio T; Kumabe N; Hirayama A
Am J Cardiol; 2010 Jan; 105(2):144-8. PubMed ID: 20102908
[TBL] [Abstract][Full Text] [Related]
19. Comparison of effects of serum n-3 to n-6 polyunsaturated fatty acid ratios on coronary atherosclerosis in patients treated with pitavastatin or pravastatin undergoing percutaneous coronary intervention.
Nozue T; Yamamoto S; Tohyama S; Fukui K; Umezawa S; Onishi Y; Kunishima T; Sato A; Nozato T; Miyake S; Takeyama Y; Morino Y; Yamauchi T; Muramatsu T; Hibi K; Terashima M; Michishita I
Am J Cardiol; 2013 Jun; 111(11):1570-5. PubMed ID: 23497779
[TBL] [Abstract][Full Text] [Related]
20. Association of body mass index with coronary plaque regression: 6-month prospective study.
Tani S; Nagao K; Anazawa T; Kawamata H; Furuya S; Takahashi H; Iida K; Matsumoto M; Washio T; Kumabe N; Hirayama A
J Atheroscler Thromb; 2009 Jun; 16(3):275-82. PubMed ID: 19556715
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
